IL22 and chronic obstructive pulmonary disease: The IL-17A and IL-22 levels were increased in COPD stages III and IV compared to the other groups, and sputum IL-17A levels in COPD patients were positively correlated with sputum neutrophils, enhancing the inflammatory process (16).